fda university review board researchers said start clinical trial end year chinese trial enroll patients metastatic non small cell lung cancer treatment options limited says lu technique great promise bringing benefits patients especially cancer patients treat day lu team extract immune cells called t cells blood enrolled patients use pairs molecular guide able identify specific genetic sequences chromosome enzyme snip chromosome spot knock gene cells gene encodes protein called pd-1 normally acts check cell capacity launch immune response prevent attacking healthy cells gene edited cells multiplied lab introduced patient bloodstream engineered cells circulate team hopes home cancer says lu planned